Catechol-bearing imidazolium and benzimidazolium chlorides as promising antimicrobial agents.
Mert Olgun KarataşSelami GünalAhmet MansurBülent Alıcıİsmail ÖzdemirPublished in: Archiv der Pharmazie (2020)
Catechol-containing imidazolium (four) and benzimidazolium chlorides (eight) were synthesized to evaluate their antimicrobial properties. All the compounds were fully characterized using 1 H and 13 C nuclear magnetic resonance, liquid chromatography-mass spectrometry, infrared spectroscopic methods, and elemental analyses. Antimicrobial activities of the compounds were tested against the bacteria Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella pneumoniae, Staphylococcus aureus, methicillin-resistant S. aureus (MRSA), Enterococcus faecalis, and the fungal strains Candida albicans and Candida glabrata, and promising results were achieved. The two most important benzyl-substituted benzimidazolium chlorides, 3l and 3k, showed comparable activity to vancomycin against MRSA.
Keyphrases
- staphylococcus aureus
- biofilm formation
- candida albicans
- acinetobacter baumannii
- klebsiella pneumoniae
- escherichia coli
- methicillin resistant staphylococcus aureus
- multidrug resistant
- pseudomonas aeruginosa
- mass spectrometry
- liquid chromatography
- magnetic resonance
- ionic liquid
- drug resistant
- molecular docking
- high resolution mass spectrometry
- cystic fibrosis
- gas chromatography
- high resolution
- capillary electrophoresis
- high performance liquid chromatography
- simultaneous determination